Rapamycin (sirolimus) inhibits proliferating cell nuclear antigen expression and blocks cell cycle in the G1 phase in human keratinocyte stem cells.

Por Javier, A. F., Bata-Csorgo, Z., Ellis, C. N., Kang, S., Voorhees, J. J., Cooper, K. D.
Publicado em 1997